NCT00193713View on ClinicalTrials.gov

Bifeprunox in the Treatment of Schizophrenia

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Schizophrenia
Interventions
DRUG

bifeprunox

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00193713 - Bifeprunox in the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter